# Corvel Corp: overview

CRVL · Nasdaq · CIK 874866 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/crvl.md) · [Financials](/companies/crvl/financials.md) · [Filings](/companies/crvl/filings.md) · [Insiders](/companies/crvl/insiders.md)

Latest reported revenue: [$259.9m](/filings/0001193125-26-338216.md) for Q1 FY2027, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-338216).

## Last eight quarters

| Line item | Unit | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [224](/filings/0001193125-25-269721.md) | [228](/filings/0001193125-26-039480.md) | [232 d](/filings/0001193125-26-237024.md) | [235](/filings/0001193125-26-338216.md) | [240](/filings/0001193125-25-269721.md) | [236](/filings/0001193125-26-039480.md) | [249 d](/filings/0001193125-26-237024.md) | [260](/filings/0001193125-26-338216.md) |
| Gross margin | % | [22.6%](/filings/0001193125-25-269721.md) | [23.2%](/filings/0001193125-26-039480.md) | [25.1% d](/filings/0001193125-26-237024.md) | [24.2%](/filings/0001193125-26-338216.md) | [24.3%](/filings/0001193125-25-269721.md) | [23.3%](/filings/0001193125-26-039480.md) | [25.4% d](/filings/0001193125-26-237024.md) | [26.1%](/filings/0001193125-26-338216.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [10.4%](/filings/0001193125-25-269721.md) | [10.4%](/filings/0001193125-26-039480.md) | [11.4% d](/filings/0001193125-26-237024.md) | [11.6%](/filings/0001193125-26-338216.md) | [11.6%](/filings/0001193125-25-269721.md) | [10.3%](/filings/0001193125-26-039480.md) | [12.5% d](/filings/0001193125-26-237024.md) | [12.4%](/filings/0001193125-26-338216.md) |
| Diluted EPS | $ per share | [0.45](/filings/0001193125-25-269721.md) | [0.46](/filings/0001193125-26-039480.md) | not reported | [0.52](/filings/0001193125-26-338216.md) | [0.54](/filings/0001193125-25-269721.md) | [0.47](/filings/0001193125-26-039480.md) | not reported | [0.63](/filings/0001193125-26-338216.md) |
| Free cash flow | $m | [12.4 d](/filings/0001193125-25-269721.md) | [32.1 d](/filings/0001193125-26-039480.md) | [14.3 d](/filings/0001193125-26-237024.md) | [39.5](/filings/0001193125-26-338216.md) | [15.3 d](/filings/0001193125-25-269721.md) | [35.2 d](/filings/0001193125-26-039480.md) | [20.3 d](/filings/0001193125-26-237024.md) | [43.1](/filings/0001193125-26-338216.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [646](/filings/0000950170-24-064645.md) | [719](/filings/0000950170-25-076999.md) | [795](/filings/0001193125-26-237024.md) | [896](/filings/0001193125-26-237024.md) | [959](/filings/0001193125-26-237024.md) |
| Gross margin | % | [23.5%](/filings/0000950170-24-064645.md) | [22.0%](/filings/0000950170-25-076999.md) | [21.6%](/filings/0001193125-26-237024.md) | [23.4%](/filings/0001193125-26-237024.md) | [24.3%](/filings/0001193125-26-237024.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [10.3%](/filings/0000950170-24-064645.md) | [9.2%](/filings/0000950170-25-076999.md) | [9.6%](/filings/0001193125-26-237024.md) | [10.6%](/filings/0001193125-26-237024.md) | [11.5%](/filings/0001193125-26-237024.md) |
| Diluted EPS | $ per share | [3.66](/filings/0000950170-24-064645.md) | [1.26](/filings/0000950170-25-076999.md) | [1.47](/filings/0001193125-26-237024.md) | [1.83](/filings/0001193125-26-237024.md) | [2.14](/filings/0001193125-26-237024.md) |
| Free cash flow | $m | [37.4](/filings/0000950170-24-064645.md) | [56.0](/filings/0000950170-25-076999.md) | [70.0](/filings/0001193125-26-237024.md) | [91.6](/filings/0001193125-26-237024.md) | [110](/filings/0001193125-26-237024.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/crvl/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $321.3m | 5,139,406 |  | Added +262,510 |
| [KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC](/funds/1021223.md) | 2026-06-30 | $284.5m | 4,551,195 |  | Reduced −319,794 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $107.5m | 1,719,876 |  | Added +28,477 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $95.6m | 1,529,530 |  | Reduced −88,300 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $81.2m | 1,298,302 |  | Added +1,310 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $80.6m | 1,289,247 |  | Added +80,056 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $71.0m | 1,136,109 |  | Reduced −24,444 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $63.4m | 1,013,570 |  | Added +76,018 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $41.0m | 655,700 |  | Reduced −39,206 |
| [WELLS FARGO & COMPANY/MN](/funds/72971.md) | 2026-06-30 | $28.3m | 453,149 |  | Reduced −8,773 |

## Recent filings

[All 1,699 filings](/companies/crvl/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-11 | 21:24 ET | [8-K](/filings/0001193125-26-345046.md) | 5.07 Shareholder vote results | 0001193125-26-345046 |
| 2026-08-06 | 20:30 ET | [10-Q](/filings/0001193125-26-338216.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338216 |
| 2026-08-05 | 23:37 ET | [8-K](/filings/0001193125-26-333384.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-333384 |
| 2026-06-26 | 20:16 ET | [DEF 14A](/filings/0001193125-26-285509.md) | Proxy statement, period 2026-08-06 | 0001193125-26-285509 |
| 2026-06-01 | 21:05 ET | [8-K](/filings/0001193125-26-251709.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-251709 |
| 2026-05-22 | 20:30 ET | [10-K](/filings/0001193125-26-237024.md) | Annual report, period 2026-03-31 | 0001193125-26-237024 |
| 2026-05-20 | 23:30 ET | [8-K](/filings/0001193125-26-231354.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-231354 |
| 2026-02-05 | 21:30 ET | [10-Q](/filings/0001193125-26-039480.md) | Quarterly report, period 2025-12-31 | 0001193125-26-039480 |
| 2026-02-03 | 00:30 ET | [8-K](/filings/0001193125-26-034033.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-034033 |
| 2025-11-06 | 21:30 ET | [10-Q](/filings/0001193125-25-269721.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269721 |

## Latest annual report

[Form 10-K for the fiscal year ended Mar 31, 2026](/filings/0001193125-26-237024.md), filed May 22, 2026.

## Forecast league

Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/dbfa3631-bf77-40e7-9092-ab7371629803)

## About the filer

- CIK: 874866
- Tickers: CRVL
- Exchange: Nasdaq
- SIC code: 6411 Insurance Agents, Brokers & Service
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.